Table 2 Characteristics of Baseline Information in Participants who Completed All the Measures versus Some of the Measures
All measures completed (n = 68) | Some measures completed (n = 89) | t/χ2 | P | ||
|---|---|---|---|---|---|
M±SD/n (%) | M±SD/n (%) | ||||
Age | 58.7±10.5 | 57.8±9.0 | 0.587 | 0.558 | |
Gender | male | 46 (67.6%) | 57 (64.0%) | 0.222 | 0.638 |
female | 22 (32.4%) | 32 (36.0%) | |||
Residence | city | 55 (80.9%) | 63 (70.8%) | 2.104 | 0.147 |
rural | 13 (19.1%) | 26 (29.2%) | |||
Cancer | colorectal | 9 (13.2%) | 19 (21.3%) | 1.963 | 0.743 |
rectal | 18 (26.5%) | 22 (24.7%) | |||
gastric | 15 (22.1%) | 16 (18.0%) | |||
thyroid | 22 (32.4%) | 26 (29.2%) | |||
other | 4 (5.9%) | 6 (6.7%) | |||
Cancer periods | I | 5 (7.4%) | 11 (12.4%) | 7.338 | 0.062 |
II | 23 (33.8%) | 25 (28.1%) | |||
III | 31 (45.6%) | 28 (31.5%) | |||
IV | 9 (13.2%) | 25 (28.1%) | |||
Past operation | yes | 23 (33.8%) | 39 (48.3%) | 1.612 | 0.204 |
no | 45 (66.2%) | 50 (56.2%) | |||
Past chemotherapy | yes | 22 (32.4%) | 35 (39.3%) | 0.810 | 0.368 |
no | 46 (67.6%) | 54 (60.7%) | |||
Past targeted therapy | yes | 4 (5.9%) | 9 (10.1%) | 0.908 | 0.341 |
no | 64 (94.1%) | 80 (89.9%) | |||
Past radiotherapy | yes | 8 (11.8%) | 16 (18.0%) | 1.149 | 0.284 |
no | 60 (88.2%) | 73 (82.0%) |